What can biobanks do against COVID-19? Taking care of today’s COVID-19 patients is priority number 1. Researchers will need high quality samples from patients and healthy controls, collected in clinical settings and in an ethical way. BBMRI-ERIC can all help with that. In the past weeks, BBRMI collected information on the resources national nodes and…
The GA4GH meeting was online due to the Covid-19 outbreak. The level of participation and engagement of participants coming from different geographical locations have motivated the organizers to develop resources and materials collected during the virtual meeting and make them available to everyone. Here are the links to view the Meeting Reports on the website…
There is no anti-Covid-19 drug globally accepted for treatment, but many drugs are under investigations. About 16 trials of antivirals are under development (6 march 2020). Antiviral drugs are difficult to find, because of the cell-parasitic nature of viruses. It has been long to get efficient drugs against HIV or Hepatitis C. COVID-19 vaccine may…
EURORDIS has launched a new contribution on ERNs and health data to trigger a strategic discussion on health data and ERNs that will allow the Networks to have a long-term strategy that is aligned with their needs and ambition. The proposal aims to progress towards developing a comprehensive ERN data strategy that is structured around…